In my day-job I am forced to write my economic outlook for the new year in December, alongside most other economists. This is part of a long-standing sell-side tradition, and at Christmas time, you don’t change traditions. The real way to do it, however, is to way a few weeks into January to see where the dust settles and how investors vote with their money in the early sessions of the year. I thus present the Alpha Sources version; five key questions for 2023, and as many answers. I’ll start with the war in Russia, asking what in fact Russia will achieve, if anything. I then ask whether 60/40 portfolio will rebound in 2023, and whether the leadership in global equities is changing. I then qualify my answer with a question on geopolitics and the free flow of goods and capital between China and the US, before asking whether Covid is over.
Read MoreApart from soul-searching on the endgame for Covid—see my version here—the arrival of Omicron seems to have had two relatively predictable effects on financial markets. Volatility has shot higher, and the yield curve has flattened. Put differently, stocks have sold off, and the long bond has rallied. The MSCI World is down just under 4% from its peak at the start of November, and the U.S. 10-year yield is off some 25bp. Neither of these numbers are dramatic, but they’re eye-catching, all the same. I suspect these shifts are driven by both fears of Omicron—despite little hard evidence that it is the vaccine-evading super-bug everyone has feared—and the fact that monetary policymakers so far have had little interest in changing their stance. More specifically, Fed officials have said nothing to shift expectations that it is expected to taper QE to zero by the middle of next year, and start raising rates shortly thereafter.
Read MoreEveryone has a plan until they get kicked in the nuts by a new virus variant, apparently. The speed with which markets deteriorated on Friday on the news that the B.1.1.529 variant—first detected in South Africa and Botswana, but now confirmed in both Europe and Asia—was telling. So is the swiftness with which many countries already are digging deep in the pre-vaccination toolbox of travel restrictions and, inevitably, domestic restrictions of some form. Indeed, even before the new variant, recently renamed ominously to Omicron, arrived on the scene, Europe was inching closer to new restrictions. Austria and Netherlands were in full or semi-lockdown before Friday, and given the direction of numbers in the major economies, it was only a matter of time before more widespread restrictions were introduced. So, here we are; 18 months of rolling lockdowns and travel restrictions, trillion of dollars in public support, and around 70% of the adult population double-jabbed—and shall we say another 10% with immunity from previous infection?—and we’re back to square one. Someone, somewhere, will soon have to start asking questions, but maybe not yet.
Read More